{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T01:01:19Z","timestamp":1751245279511},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,8]]},"DOI":"10.7759\/cureus.66456","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T16:20:55Z","timestamp":1723134055000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Diagnostic Complexity of Diabetes Subtypes in Pediatric Obesity: A Case Report of an Adolescent With Prader-Willi Phenotype and Literature Review"],"prefix":"10.7759","author":[{"given":"Anca A","family":"Boboc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara I","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tataranu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Boboc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Galos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Obesity in children & adolescents","volume":"132","author":"Raj M","year":"2010","unstructured":"Raj M, Kumar RK. Obesity in children &amp; adolescents. Indian J Med Res. 2010, 132:598-607.","journal-title":"Indian J Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00025-6","article-title":"Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study","volume":"11","author":"Wagenknecht LE","year":"2023","unstructured":"Wagenknecht LE, Lawrence JM, Isom S, et al.. Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study. Lancet Diabetes Endocrinol. 2023, 11:242-50. 10.1016\/S2213-8587(23)00025-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13454","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"23","author":"Libman I","year":"2022","unstructured":"Libman I, Haynes A, Lyons S, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2022, 23:1160-74. 10.1111\/pedi.13454","journal-title":"Pediatr Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0958","article-title":"Approach to the obese adolescent with new-onset diabetes","volume":"95","author":"Zeitler P","year":"2010","unstructured":"Zeitler P. Approach to the obese adolescent with new-onset diabetes. J Clin Endocrinol Metab. 2010, 95:5163-70. 10.1210\/jc.2010-0958","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2016.07.04","article-title":"The dilemma of diagnostic testing for Prader-Willi syndrome","volume":"6","author":"Smith A","year":"2017","unstructured":"Smith A, Hung D. The dilemma of diagnostic testing for Prader-Willi syndrome. Transl Pediatr. 2017, 6:46-56. 10.21037\/tp.2016.07.04","journal-title":"Transl Pediatr"},{"key":"ref6","article-title":"Prader-Willi syndrome","author":"Fermin Gutierrez MA","year":"2024","unstructured":"Fermin Gutierrez MA, Daley SF, Mendez MD. Prader-Willi syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy SB","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012, 14:10-26. 10.1038\/gim.0b013e31822bead0","journal-title":"Genet Med"},{"key":"ref8","article-title":"Prader-Willi syndrome","author":"Driscoll DJ","year":"1993","unstructured":"Driscoll DJ, Miller JL, Cassidy SB. Prader-Willi syndrome. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al (ed): University of Washington, Seattle, Seattle, WA; 1993."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108885","article-title":"SARS-CoV-2 positive serology and islet autoantibodies in newly diagnosed pediatric cases of type 1 diabetes mellitus: a single-center cohort study","volume":"24","author":"Boboc AA","year":"2023","unstructured":"Boboc AA, Novac CN, Marin AG, et al.. SARS-CoV-2 positive serology and islet autoantibodies in newly diagnosed pediatric cases of type 1 diabetes mellitus: a single-center cohort study. Int J Mol Sci. 2023, 24:8885. 10.3390\/ijms24108885","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060551","article-title":"The impact of SARS-CoV-2 pandemic on the new cases of T1DM in children. a single-centre cohort study","volume":"11","author":"Boboc AA","year":"2021","unstructured":"Boboc AA, Novac CN, Ilie MT, et al.. The impact of SARS-CoV-2 pandemic on the new cases of T1DM in children. a single-centre cohort study. J Pers Med. 2021, 11:551. 10.3390\/jpm11060551","journal-title":"J Pers Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.7.1050","article-title":"The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography","volume":"18","author":"Zimmet PZ","year":"1995","unstructured":"Zimmet PZ. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography. Diabetes Care. 1995, 18:1050-64. 10.2337\/diacare.18.7.1050","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9016148","article-title":"Prevalence of positive diabetes-associated autoantibodies among type 2 diabetes and related metabolic and inflammatory differences in a sample of the Bulgarian population","volume":"2017","author":"Zaharieva ET","year":"2017","unstructured":"Zaharieva ET, Velikova TV, Tsakova AD, Kamenov ZA. Prevalence of positive diabetes-associated autoantibodies among type 2 diabetes and related metabolic and inflammatory differences in a sample of the Bulgarian population. J Diabetes Res. 2017, 2017:9016148. 10.1155\/2017\/9016148","journal-title":"J Diabetes Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2007.00237.x","article-title":"Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes","volume":"8","author":"Zeitler P","year":"2007","unstructured":"Zeitler P, Epstein L, Grey M, Hirst K, Kaufman F, Tamborlane W, Wilfley D. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007, 8:74-87. 10.1111\/j.1399-5448.2007.00237.x","journal-title":"Pediatr Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0373","article-title":"The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study","volume":"33","author":"Klingensmith GJ","year":"2010","unstructured":"Klingensmith GJ, Pyle L, Arslanian S, et al.. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010, 33:1970-5. 10.2337\/dc10-0373","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.24.2716","article-title":"Incidence of diabetes in youth in the United States","volume":"297","author":"Dabelea D","year":"2007","unstructured":"Dabelea D, Bell RA, D'Agostino RB Jr, et al.. Incidence of diabetes in youth in the United States. JAMA. 2007, 297:2716-24. 10.1001\/jama.297.24.2716","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1691-9","article-title":"IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)","volume":"48","author":"Bottazzo GF","year":"2005","unstructured":"Bottazzo GF, Bosi E, Cull CA, et al.. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia. 2005, 48:703-8. 10.1007\/s00125-005-1691-9","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)03062-6","article-title":"UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group","volume":"350","author":"Turner R","year":"1997","unstructured":"Turner R, Stratton I, Horton V, et al.. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet. 1997, 350:1288-93. 10.1016\/s0140-6736(97)03062-6","journal-title":"Lancet"},{"key":"ref18","article-title":"Autoantibodies in children with type 2 diabetes mellitus","volume":"15 Suppl 1","author":"Umpaichitra V","year":"2002","unstructured":"Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002, 15 Suppl 1:525-30.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1713","article-title":"Timing of initial cereal exposure in infancy and risk of islet autoimmunity","volume":"290","author":"Norris JM","year":"2003","unstructured":"Norris JM, Barriga K, Klingensmith G, Hoffman M, Eisenbarth GS, Erlich HA, Rewers M. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. JAMA. 2003, 290:1713-20. 10.1001\/jama.290.13.1713","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.088229","article-title":"Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?","volume":"91","author":"Reinehr T","year":"2006","unstructured":"Reinehr T, Schober E, Wiegand S, Thon A, Holl R. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?. Arch Dis Child. 2006, 91:473-7. 10.1136\/adc.2005.088229","journal-title":"Arch Dis Child"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2011.00846.x","article-title":"Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study","volume":"13","author":"Laffel L","year":"2012","unstructured":"Laffel L, Chang N, Grey M, et al.. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study. Pediatr Diabetes. 2012, 13:369-75. 10.1111\/j.1399-5448.2011.00846.x","journal-title":"Pediatr Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12264","article-title":"Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study","volume":"17","author":"Kelsey MM","year":"2016","unstructured":"Kelsey MM, Geffner ME, Guandalini C, Pyle L, Tamborlane WV, Zeitler PS, White NH. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatr Diabetes. 2016, 17:212-21. 10.1111\/pedi.12264","journal-title":"Pediatr Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13426","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents","volume":"23","author":"Greeley SA","year":"2022","unstructured":"Greeley SA, Polak M, Nj\u00f8lstad PR, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2022, 23:1188-211. 10.1111\/pedi.13426","journal-title":"Pediatr Diabetes"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1616","article-title":"The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes","volume":"34","author":"Greeley SA","year":"2011","unstructured":"Greeley SA, John PM, Winn AN, et al.. The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes. Diabetes Care. 2011, 34:622-7. 10.2337\/dc10-1616","journal-title":"Diabetes Care"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2962-5","article-title":"Improved genetic testing for monogenic diabetes using targeted next-generation sequencing","volume":"56","author":"Ellard S","year":"2013","unstructured":"Ellard S, Lango Allen H, De Franco E, et al.. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. Diabetologia. 2013, 56:1958-63. 10.1007\/s00125-013-2962-5","journal-title":"Diabetologia"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.6065\/apem.2016.21.4.212","article-title":"Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes","volume":"21","author":"Lee SH","year":"2016","unstructured":"Lee SH, Yu J. Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes. Ann Pediatr Endocrinol Metab. 2016, 21:212-8. 10.6065\/apem.2016.21.4.212","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00191","article-title":"Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms","volume":"39","author":"Corbin KD","year":"2018","unstructured":"Corbin KD, Driscoll KA, Pratley RE, Smith SR, Maahs DM, Mayer-Davis EJ. Obesity in type 1 diabetes: pathophysiology, clinical impact, and mechanisms. Endocr Rev. 2018, 39:629-63. 10.1210\/er.2017-00191","journal-title":"Endocr Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S223618","article-title":"Obesity in patients with type 1 diabetes: links, risks and management challenges","volume":"14","author":"Vilarrasa N","year":"2021","unstructured":"Vilarrasa N, San Jose P, Rubio M\u00c1, Lecube A. Obesity in patients with type 1 diabetes: links, risks and management challenges. Diabetes Metab Syndr Obes. 2021, 14:2807-27. 10.2147\/DMSO.S223618","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-022-03396-6","article-title":"Bardet-Biedl syndrome: a case series","volume":"16","author":"Elawad OA","year":"2022","unstructured":"Elawad OA, Dafallah MA, Ahmed MM, et al.. Bardet-Biedl syndrome: a case series. J Med Case Rep. 2022, 16:169. 10.1186\/s13256-022-03396-6","journal-title":"J Med Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2174\/138920211795677912","article-title":"Alstr\u00f6m syndrome: genetics and clinical overview","volume":"12","author":"Marshall JD","year":"2011","unstructured":"Marshall JD, Maffei P, Collin GB, Naggert JK. Alstr\u00f6m syndrome: genetics and clinical overview. Curr Genomics. 2011, 12:225-35. 10.2174\/138920211795677912","journal-title":"Curr Genomics"},{"key":"ref31","article-title":"Cohen syndrome","author":"Wang H","year":"1993","unstructured":"Wang H, Falk MJ, Wensel C, Traboulsi EI. Cohen syndrome. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al (ed): University of Washington, Seattle, Seattle, WA; 1993."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2008.165","article-title":"Prader-Willi syndrome","volume":"17","author":"Cassidy SB","year":"2009","unstructured":"Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009, 17:3-13. 10.1038\/ejhg.2008.165","journal-title":"Eur J Hum Genet"},{"key":"ref33","article-title":"Prader-Willi syndrome: consensus diagnostic criteria","volume":"91","author":"Holm VA","year":"1993","unstructured":"Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993, 91:398-402.","journal-title":"Pediatrics"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.19125\/jmrd.2016.2.2.35","article-title":"An update on Prader-Willi syndrome with diabetes mellitus","volume":"2","author":"Lee JE","year":"2016","unstructured":"Lee JE. An update on Prader-Willi syndrome with diabetes mellitus. J MPS Rare Dis. 2016, 2:35-7. 10.19125\/jmrd.2016.2.2.35","journal-title":"J MPS Rare Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-020-1284-5","article-title":"Update on diabetes mellitus and glucose metabolism alterations in Prader-Willi syndrome","volume":"20","author":"Crin\u00f2 A","year":"2020","unstructured":"Crin\u00f2 A, Grugni G. Update on diabetes mellitus and glucose metabolism alterations in Prader-Willi syndrome. Curr Diab Rep. 2020, 20:7. 10.1007\/s11892-020-1284-5","journal-title":"Curr Diab Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader-Willi syndrome","volume":"155A","author":"Miller JL","year":"2011","unstructured":"Miller JL, Lynn CH, Driscoll DC, et al.. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011, 155A:1040-9. 10.1002\/ajmg.a.33951","journal-title":"Am J Med Genet A"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.34171","article-title":"Physical health problems in adults with Prader-Willi syndrome","volume":"155A","author":"Sinnema M","year":"2011","unstructured":"Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, van Nieuwpoort IC, Drent ML, Curfs LM, Schrander-Stumpel CT. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A. 2011, 155A:2112-24. 10.1002\/ajmg.a.34171","journal-title":"Am J Med Genet A"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1017\/s001216220100202x","article-title":"Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study","volume":"44","author":"Butler JV","year":"2002","unstructured":"Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002, 44:248-55. 10.1017\/s001216220100202x","journal-title":"Dev Med Child Neurol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jir.12140","article-title":"Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France","volume":"59","author":"Laurier V","year":"2015","unstructured":"Laurier V, Lapeyrade A, Copet P, et al.. Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France. J Intellect Disabil Res. 2015, 59:411-21. 10.1111\/jir.12140","journal-title":"J Intellect Disabil Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000313377","article-title":"Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database","volume":"74","author":"Diene G","year":"2010","unstructured":"Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H, Tauber M. Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database. Horm Res Paediatr. 2010, 74:121-8. 10.1159\/000313377","journal-title":"Horm Res Paediatr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0702-5","article-title":"Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience","volume":"12","author":"Yang A","year":"2017","unstructured":"Yang A, Kim J, Cho SY, Jin DK. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience. Orphanet J Rare Dis. 2017, 12:146. 10.1186\/s13023-017-0702-5","journal-title":"Orphanet J Rare Dis"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000248","article-title":"Prader-Willi syndrome: endocrine manifestations and management","volume":"64","author":"Alves C","year":"2020","unstructured":"Alves C, Franco RR. Prader-Willi syndrome: endocrine manifestations and management. Arch Endocrinol Metab. 2020, 64:223-34. 10.20945\/2359-3997000000248","journal-title":"Arch Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1306330","article-title":"Diabetes mellitus in children and adolescents with genetic syndromes","volume":"120","author":"Schmidt F","year":"2012","unstructured":"Schmidt F, Kapellen TM, Wiegand S, et al.. Diabetes mellitus in children and adolescents with genetic syndromes. Exp Clin Endocrinol Diabetes. 2012, 120:579-85. 10.1055\/s-0032-1306330","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2007.03.367","article-title":"Autoimmune development in phenotypic type 2 diabetes patients","volume":"123","author":"Brooks-Worrell B","year":"2007","unstructured":"Brooks-Worrell B, Ismail H, Wotring M, et al.. Autoimmune development in phenotypic type 2 diabetes patients. Clinical Immunology. 2007, 123:66-7. 10.1016\/j.clim.2007.03.367","journal-title":"Clinical Immunology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02145-x","article-title":"Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition","volume":"23","author":"Bielka W","year":"2024","unstructured":"Bielka W, Przezak A, Mol\u0119da P, Pius-Sadowska E, Machali\u0144ski B. Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol. 2024, 23:62. 10.1186\/s12933-024-02145-x","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276635-exploring-the-diagnostic-complexity-of-diabetes-subtypes-in-pediatric-obesity-a-case-report-of-an-adolescent-with-prader-willi-phenotype-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T16:21:21Z","timestamp":1723134081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276635-exploring-the-diagnostic-complexity-of-diabetes-subtypes-in-pediatric-obesity-a-case-report-of-an-adolescent-with-prader-willi-phenotype-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,8]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.66456","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,8]]}}}